fda ban tirzepatide 🚨 Important Update on Compounded 🚨, As of March 19th, the has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable Did the FDA Ban Compounded

The worlds largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties created a high risk of consumer confusion and deception as well as potential safety concerns considering compounded products do not have the same safety, quality and effectiveness assurances that its products, approved by Food and Drug Administration (FDA), do

This multi-receptor engagement by MT-II produces a diverse set of physiological effects

However, high protein intake and resistance training can shift the composition toward 10 to 15% muscle and 85 to 90% fat

Signals Activation Upregulates VEGF, EGF, and growth hormone receptor expression at injury and inflammation sites throughout the body

After exclusions, the final cohort comprised 69,047 short-term users and 133,387 long-term users